Single Ascending Dose Study of WAL0921 in Healthy Subjects
Clinical trial NCT05891366 · COMPLETED
Trial details
- NCT number
- NCT05891366
- Sponsor
- Walden Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2024-01-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.